Stem Cell Therapy Used as Dog Arthritis Treatment
We have dedicated our careers to helping dogs live to the fullest extent possible. For more information please visit one of our articles below: Dog Arthritis...
By: Duncan Bulow
View original post here:
Stem Cell Therapy Used as Dog Arthritis Treatment - Video
FAQ1-Stem Cell Therapy
http://youtu.be/dJHlHBrmvrU Stem cell therapy has earned global fame for its proven ability to help sufferers of many diseases, with little ill effects or si...
By: Kerry Dean
See more here:
FAQ1-Stem Cell Therapy - Video
Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Speech h...
By: Neurogen Brain and Spine Institute
Read more here:
Stem Cell Therapy Treatment for Friedreichs Ataxia by Dr Alok Sharma, Mumbai, India. - Video
DUBLIN, July 18, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/qc7zk2/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity
Stem Cell Research in Asia-Pacific a Growth Engine for Region's Scientific Ambitions
The stem cell therapy market in Asia-Pacific is poised to offer significant contributions in the future, thanks to renewed interest by the respective governments of India, China, Japan, South Korea and Singapore to provide cures for a range of diseases, states a new report by healthcare experts GBI Research.
Stem cells are unique body cells that possess the ability to divide and differentiate into diverse cell types, and can be used to produce more stem cells. The use of adult stem cells has been successfully employed to treat bone and blood related disorders such as leukemia, through bone marrow transplants. Stem cell therapy is used to repair and regenerate the damaged tissue, though the actual mechanism of action is largely unknown.
The growth in the stem cell therapy market will not only provide treatment options but will also contribute significantly to the countries' Gross Domestic Product (GDP), with the President of South Korea only last year referring to stem cell research as a new growth engine for the nation's economy. In order to support the stem cell industry, regulatory guidelines in Asia-Pacific countries allow stem cell research, and this has led to its commercialization. India and South Korea are the leaders in the commercialization of stem cell therapy, with approved products for Acute Myocardial Infarction (AMI), osteoarthritis and anal fistula in Crohn's disease, amongst others. The countries allow the use of human embryonic stem cells and provide adequate funding support for the research.
Stem cell therapy is an emerging field, and a large amount of research is currently being carried out by institutions such as hospitals, universities and medical colleges. According to GBI Research's analysis of the stem cell therapy research in Asia-Pacific, 63% of pipeline molecules were being researched by academia. The emergence of institutional research has boosted stem cell discoveries, as companies can be put off conducting research due to uncertain therapeutic outcomes. China and Japan witness only a negligible industry presence in stem cell research, as academic institutions dominate - however in contrast, India has the presence of both industry and academia. The major institutions engaged in stem cell research in India are LV Prasad Eye Institute (LYPEI) for Limbal Stem Cell Technology (LSCT), and the Post Graduate Institute of Medical Education and Research (PGIMER) for stem cell therapy for type 2 diabetes mellitus.
The market is poised for significant growth in the future, due to the anticipated launch of JCR Pharmaceuticals' JR-031 in Japan in 2014, and FCB Pharmicell's Cerecellgram (CCG) in South Korea in 2015. GBI Research therefore predicts that the stem cell therapy market will grow in value from $545m in 2012 to $972m in 2018, at a Compound Annual Growth Rate (CAGR) of 10%.
Read the original:
Stem Cell Therapy Market in Asia-Pacific to 2018
Stem Cell Therapy - Knee Replacement Alternative
Stem Cell Therapy is a the best alternative to joint replacement. Find out how athletes are using these new innovations to overcome their pain.
By: Omar Salah
Follow this link:
Stem Cell Therapy - Knee Replacement Alternative - Video
Stem Cell Therapy Docere Clinics
By: KeysToYoungerLiving
See the article here:
Stem Cell Therapy Docere Clinics - Video
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 7 months after Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Emotional respons...
By: Neurogen Brain and Spine Institute
Read the original here:
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2 - Video
Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Fle...
By: Neurogen Brain and Spine Institute
Go here to see the original:
Stem Cell Therapy Treatment for Idiopathic Polymyositis by Dr Alok Sharma, Mumbai, India. - Video
Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Ball throw...
By: Neurogen Brain and Spine Institute
Read the original here:
Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. Part 2 - Video
Freeport, Bahamas (PRWEB) July 17, 2013
Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has named Leslie Miller, M.D., F.A.C.C. as its chief science officer. Dr. Miller is a leading heart failure specialist and experienced thought leader in cardiac stem cell therapy. He is director of the University of South Florida (USF) Heart Institute, professor of cardiovascular sciences at the USF Health Morsani College of Medicine, and was formerly the director of cardiology at Georgetown University. Dr. Miller has been an investigator in over 80 clinical trials.
The use of adult stem cells derived from adipose (fat) tissue to treat congestive heart failure has the potential to change the game for the millions of patients suffering from this disease, said Miller. These stem and regenerative cells have been shown to stimulate the growth of new blood vessels, are anti-inflammatory and prevent at-risk cells from dying. These combined mechanisms can provide important therapeutic benefit to heart failure patients.
As a current member of Okyanos medical advisory council, Dr. Miller has actively advised us on patients criteria for cardiac stem cell therapy, says Okyanos Chief Medical Officer Howard Walpole. In this additional role as Chief Science Officer, he will be evaluating new research protocols and reporting on findings from the patient registry that will help advance the field of cardiac stem cell therapy. His experience and track record in leading academic research is outstanding. This integrated approach in research and clinical application in The Bahamas makes Okyanos Heart Institute one of the first places patients can receive new treatments.
Dr. Leslie Miller is a well-respected visionary in the field of cardiovascular disease says Okyanos CEO Matt Feshbach. This role will further advance our quality measures and the structure of our patient registry. We look forward to his contribution to improving the lives of patients using adult stem cells derived from their own fat tissue who, up until now, have exhausted their options with conventional treatments.
ABOUT OKYANOS HEART INSTITUTE: (Oh key AH nos) Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.A.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive catheterization, stimulates the growth of new blood vessels, a process known as angiogenesis. The treatment facilitates blood flow in the heart and supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos (Oceanos) symbolizes flow. For more information, go to http://www.okyanos.com/.
NEW MEDIA CONTENT: Okyanos LinkedIn page: http://www.linkedin.com/company/okyanos-heart-institute
Okyanos Facebook page: https://www.facebook.com/OKYANOS
Okyanos Twitter page: https://twitter.com/#!/OkyanosHeart
END
Continued here:
Dr. Leslie Miller Named Chief Science Officer of Okyanos Heart Institute's Cardiac Stem Cell Therapy Treatment for ...
stem cell therapy for Sports injuries.
Videos is about the Stem Cell Treatment provided to various athletes and sports persons. Dr. Purita had provided treatment for the knee, elbow, shoulder, wri...
By: Stem Md
Read the rest here:
stem cell therapy for Sports injuries. - Video
Stem Cell Therapy Treatment for Left Hemiplegic Cerebral Palsy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Left Hemiplegic Cerebral Palsy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...
By: Neurogen Brain and Spine Institute
Continue reading here:
Stem Cell Therapy Treatment for Left Hemiplegic Cerebral Palsy by Dr Alok Sharma, Mumbai, India. - Video
Life stem cell therapy Purtier
9 years old girl benefited from deer placenta.
By: Keith Chew
Continue reading here:
Life stem cell therapy Purtier - Video
Habib Torfi and stem cell therapy at Invitrx Therapeutics
Stem Cell Therapy.
By: Habib Torfi
See the rest here:
Habib Torfi and stem cell therapy at Invitrx Therapeutics - Video
Thor, an athletic 7-year-old Catahoula leopard hound, lay on a table at the Animal Clinic of Billings, panting lightly while staffers put small bags over his feet and temperature-controlled packs on his chest before the anesthesia kicked in.
Not long after he went under, those same staff members carried Thor to an operating table where his owner, Dr. Bobbi Jo Massic, who is also a veterinarian at the clinic, made a small incision in his abdomen, the first step in a cutting-edge process designed to help the alleviate the dogs hip dysplasia and arthritis.
By the end of Tuesday, Thor became the very first patient in the clinics brand new animal stem cell therapy program.
This is a very exciting day, said Dr. Bryna Felchle, another vet at the clinic who will help spearhead the program. Were launching our very first stem cell therapy right here.
The process is widespread across the United States, but Felchle is just the second vet in Montana certified to perform the procedure and the only one in the eastern half of the state.
Generally, it involves removing fatty tissue from an animal, separating the stem cells from that tissue, activating the cells and then injecting or applying them back into the animal to promote healing or tissue growth.
The stem cells which differentiate and adapt into needed cells and tissues help to treat arthritis, hip dysplasia, ligament and cartilage injuries and other degenerative diseases.
Massic said Thor is a very active dog. Several years ago, he tore an anterior cruciate ligament, for which he underwent three surgeries and has a metal plate and three screws in one of his legs, along with the arthritis and dysplasia.
He has a lot of his active life ahead of him, she said. Were hoping that we can get him back to that mobility he had before.
She also said it could cut down on healing time, since the surgery requires fairly small incisions and a simple injection of the cells later.
Read more:
Billings veterinary clinic conducts city's first dog stem cell therapy treatment
Manila, Philippines -- If she would have her way, Dr. Marita V.T. Reyes, Co-Chairperson of the Philippine Health Research Ethics Board (PHREB), yesterday said she would put a stop to the medical procedure of stem cell therapy.
Reyes delivered a paper yesterday on the topic, "Ethical Consideration In Stem Cell-based Therapy and Research-Poor Countries," on the last day of the 35th Annual Scientific Meeting of the Department of Science and Technology-National Academy of Science and Technology (DOST-NAST) at the historic landmark Manila Hotel.
Reyes acknowledged that there is a "standard" stem cell therapy treatment involving "hematopoietic disorders," such as "leukemia and lymphomas," through "bone marrow or cord blood transplant."
She, however, emphasized that this cannot be said yet in the cases of diseases of the heart, eyes, diabetes, stroke, spinal cord injury, Parkinson's, Alzheimer's, Lou Gehrig's (ALS), multiple sclerosis, cancer, and cartilage repair.
Stem cell therapy for these diseases, she stressed, should be stopped.
"If I have the power, I will say, 'stop this in the meantime, until the Food and Drug Administration (FDA) has come up with a quality assurance. Until the FDA is able to say that what you say is there, is there, we have no way of protecting our people," said Reyes, when asked about the ethics board's possible advice.
"So, as far as I am concerned, I would like the stem cell therapy, meaning for people who are saying they are using stem cell therapy, to stop, until we have set up very clear quality assurance (system)," the PHREB official said.
Stem cell therapy discussions resulted from the reported death of three Filipino politicians, and the complaint of a government official, after allegedly subjecting themselves from the controversial medical procedure.
Dr. Francisco Chung, Jr., of the Makati Medical Center (MMC), on the other hand, conceded that there are many stem cell procedures that are "experimental in nature."
"What we have approved clinically is bone marrow transplantation," he said, citing the approval of the United States Food and Drug Administration (USFDA).
Read more:
Stop stem cell therapy – Doctor
Stem cell therapy future of medicine?
Everyone is talking about stem cell therapy. But scammers and swindlers are also taking advantage of the fad, prompting the Health Department to step in. Bue...
By: Rappler
Freeport, The Bahamas (PRWEB) July 09, 2013
Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has announced that Antonio Colombo, M.D., F.A.C.C. has joined the esteemed group of Okyanos medical advisory council members. Dr. Colombo is director of the Cardiac Catheterization Laboratory at Columbus Hospital and chief of invasive cardiology at San Raffaele Hospital, both in Milan, Italy, and is a visiting professor of medicine at Columbia Medical Center in New York, USA.
Dr. Colombo is a pioneer of the coronary stent placement concept, and he helped define the role of intravascular ultrasound in stent placement. In addition, he was the principal investigator for a cardiac stem cell therapy trial at San Raffaele Hospital, which treated patients with chronic angina.
Okyanos Chief Medical Officer Howard T. Walpole Jr. stated, Dr. Colombo is a leading innovator in cardiology. I welcome his contribution to Okyanos Heart Institutes goal of providing patients the highest standard of safety and care possible with the Okyanos treatment.
The use of adult stem cells derived from adipose (fat) tissue to treat coronary artery disease is an important innovation in cardiovascular care, said Colombo. I am pleased to be able to collaborate with the other members of the Okyanos medical advisory council and Dr. Walpole in bringing this new treatment option to those patients whom we believe it may benefit.
Dr. Colombos research has culminated in multiple publications in some of the most prestigious cardiology journals in the U.S. and Europe. In addition, he is very active in multiple medical societies such as the American College of Cardiology, American Heart Association, and the American College of Physicians. Dr. Colombo is also on the editorial boards of major journals such as Circulation, Journal of the American College of Cardiology, and the American Journal of Cardiovascular Drugs.
We are delighted to have the accomplished Dr. Colombo actively participating in the Okyanos medical advisory council, which already includes thought leaders such as Dr. Eric Duckers, Dr. Farrell Mendelsohn, and Dr. Leslie Miller, says Okyanos CEO Matt Feshbach. Okyanos is committed to bringing together key opinion leaders in cardiology and cardiac stem cell therapy to ensure that patients suffering from chronic coronary artery disease are treated safely and effectively with their own adult stem cells.
About Okyanos Heart Istitue: (Oh key AH nos)
Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.A.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive catheterization, stimulates the growth of new blood vessels, a process known as angiogenesis. The treatment facilitates blood flow in the heart and supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos (Oceanos) symbolizes flow. For more information, go to http://www.okyanos.com/.
by Rappler.com Posted on 07/09/2013 9:42 PM |Updated 07/10/2013 1:18 PM
MANILA, Philippines - Everyone is talking about stem cell therapy. But scammers and swindlers are also taking advantage of the fad, prompting the Health Department to step in. Buena Bernal reports.
Its the new medical buzzword in the Philippines. Stem cell therapy is a procedure which uses repair cells found in the body to replace old cells. Dr Florencio Lucero started doing the procedure 6 years ago.
DR FLORENCIO LUCERO, STEM CELL TRANSPLANT SURGEON: Stem cells can help degenerative diseases. Some people who have serious illnesses, and they cannot find any solution to their condition, they seek this kind of treatment, because it can improve their condition. But not a cure. It cannot cure.
Pilar Vazquez who went through a mild stroke says she felt energized after undergoing the treatment.
PILAR VAZQUEZ, STEM CELL TRANSPLANT PATIENT: Stem cell is very good. I did not feel pain or what. Everything is very good. Before, I dont [always] talk. Now, I always talk. Thats a very good difference, because now they say, Ay si Mommy, ang galing galing niyan, parating nagsasalita!
But stem cell therapy became controversial after 3 government officials allegedly died from the treatment, while another official filed charges against his German doctor for his botched treatment last year. Food and Drug Administration director Dr. Kenneth Hartigan Go says right now, stem cell therapy is allowed but under investigation.
DR KENNETH HARTIGAN-GO, DIRECTOR, FOOD AND DRUG ADMINISTRATION: We are keeping an objective mind and saying, okay, if this is investigational, go ahead. And then we have to see outcome, say, within a period of a time whether the product actually works or not.
The Department of Health cautions the public from engaging in prohibited forms of the treatment -- those that are performed outside accredited facilities and those that source stem cells from human embryos. Health Secretary Enrique Ona says he does not want to stifle the innovation but there must be regulation.
The rest is here:
Stem cell therapy: Future of medicine?
TAMPA, Fla., July 9, 2013 /PRNewswire/ -- Stem Cell Therapy for knee joint pain has been involved in multiple clinical trials worldwide. In the United States trials for knee arthritis and back pain with degenerative disc disease have undergone safety trials and phase studies for effectiveness. The safety profile for stem cell therapy in joints has been proven. Adverse effects are not seen as related to the stem cells. These studies were conducted with allogenic (other people's) stem cells. Naturally, if using your own stem cells, the issues which may be raised from someone else's stem cells is not a concern, and are therefore even safer. There are no immune rejection issues or communicable diseases that can be obtained by using your own cells.
Stem Cell Therapy for joints also do not carry surgical risks such as anesthesia, there is no greater risk for other postoperative complications such as blood clots, infections, or need for revision surgery if it is unsuccessful. Dr. Dennis Lox, a Regenerative and Sports Medicine physician in the Tampa Bay, Florida area (www.drlox.com), comments, "Surgery for joint replacement does carry some significant risks, as this is a highly invasive surgery. Knee and other joint replacement surgery consent forms do include the complication of death. More common problems are infection and blood clots. Stem Cell Therapy injections for joints are no more difficult than injecting cortisone into the knee," states Dr. Lox."There is preparation involved to get to that point, however the injection can be a simple, same-day, office-based procedure."
Dr. Lox notes, "Stem Cell Therapy for joint repair has been used for acute and chronic injuries, knee meniscal tears, loss of knee joint cartilage, and to stop the progression of degenerative arthritis. Even avascular necrosis (AVN) or osteonecrosis has been treated with Stem Cell Therapy. The secondary arthritis from joint collapse in avascular necrosis (AVN) can be significant leading to knee joint replacement. The useof stem cells is becoming a more common alternative to joint replacement."
Dr. Lox further notes, "Some patients may have already had one knee joint replaced with a bad outcome, and wish to avoid a second knee replacement. Others may not be healthy enough. Some medical disorders such as bad hear ailments may preclude having a knee replacement. In these cases, having a regenerative medicine procedure is an attractive, conservative option. Patients who are not medically suited for joint or knee replacement are generally good candidates for Stem Cell Therapy. The pursuit of conservative options in patients who wish to avoid surgery for joint disorders, may find Stem Cell Therapy as an attractive alternative."
About Dr. Dennis Lox Dr. Lox practices in the Tampa Bay Florida area. Dr. Lox is a Sports and Regenerative Medicine Physician, who specializes in the use of regenerative and restorative medicine to assist in treating athletic and arthritis conditions. Dr. Lox may be reached at (727) 462-5582 or visit Drlox.com.
See the rest here:
Stem Cell Therapy for Knee Pain: Safer than Surgery